Other news
First Patient Dosed with TLX250-CDx in Italy for ccRCC
The below product is manufactured at RTM First Patient dosed with TLX250-CDx in Italy for ccRCC Th...
LinkedIn post Isologic goes electric
šIsologic Goes Electric! We are excited to announce the expansion of our electric fleet with the a...
ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany
ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany! This marks the 8...
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer
The below product is manufactured at RTM First Patient Dosed in Phase II Study of TLX250-CDx in Tri...
Interested in a collaboration?
Contact us to discuss the possibilities.